Control of the size of simple kidney cysts by a combination of dietician supplement

D. Ivanov
{"title":"Control of the size of simple kidney cysts by a combination of dietician supplement","authors":"D. Ivanov","doi":"10.22141/2307-1257.10.3.2021.239592","DOIUrl":null,"url":null,"abstract":"The effectiveness of the dietary supplement Aneza is presented with a practical approach. Aneza is positioned to control the size of simple kidney cysts. The author considers the properties of dietary supplements, which became the basis for a 6-month initiative study EFFECTIVENESS OF ANESA IN SIMPLE KIDNEY CYSTS (ETAP). The POEM study design was based on evidence-based practice and was conducted as an open prospective rando­mized in one group free of charge in 60 people aged 30 to 65 years with a diagnosed cyst I–II according to Bosniak. Exclusion criteria were as follows: invasive urological history, renal failure (chronic kidney disease stage 3 and above). The average decrease in the vo­lume of the cyst on the background of receiving Aneza in the right kidney was minus 46.5 %, in the left — minus 39.9 %, on average minus 42.9 % (P ≤ 0.01). The best dynamics of cyst volume reduction was observed in women older than 40 years — 66.8 % vs. 52.5 % up to 40 years: (t = 0.97), and in men up to 40 years old: 27.1 % vs. 30.5 % (t = 0.29). The study confirms the effectiveness of Aneza in people with simple kidney cysts and, in the author’s opi­nion, a dietary supplement can be recommended as an additional means of controlling the growth of kidney cysts I–II according to Bosniak.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"KIDNEYS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22141/2307-1257.10.3.2021.239592","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The effectiveness of the dietary supplement Aneza is presented with a practical approach. Aneza is positioned to control the size of simple kidney cysts. The author considers the properties of dietary supplements, which became the basis for a 6-month initiative study EFFECTIVENESS OF ANESA IN SIMPLE KIDNEY CYSTS (ETAP). The POEM study design was based on evidence-based practice and was conducted as an open prospective rando­mized in one group free of charge in 60 people aged 30 to 65 years with a diagnosed cyst I–II according to Bosniak. Exclusion criteria were as follows: invasive urological history, renal failure (chronic kidney disease stage 3 and above). The average decrease in the vo­lume of the cyst on the background of receiving Aneza in the right kidney was minus 46.5 %, in the left — minus 39.9 %, on average minus 42.9 % (P ≤ 0.01). The best dynamics of cyst volume reduction was observed in women older than 40 years — 66.8 % vs. 52.5 % up to 40 years: (t = 0.97), and in men up to 40 years old: 27.1 % vs. 30.5 % (t = 0.29). The study confirms the effectiveness of Aneza in people with simple kidney cysts and, in the author’s opi­nion, a dietary supplement can be recommended as an additional means of controlling the growth of kidney cysts I–II according to Bosniak.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
控制单纯性肾囊肿的大小,结合营养补充剂
膳食补充剂Aneza的有效性提出了一个实用的方法。Aneza用于控制单纯性肾囊肿的大小。作者考虑了膳食补充剂的特性,这成为为期6个月的单纯性肾囊肿(ETAP)麻醉有效性研究的基础。POEM研究设计基于循证实践,作为一项开放的前瞻性随机分组,在60名年龄在30至65岁之间诊断为囊肿I-II的患者中免费进行。排除标准如下:有侵入性泌尿史,肾功能衰竭(慢性肾病3期及以上)。右肾经Aneza治疗后,囊肿体积平均减少- 46.5%,左肾- - 39.9%,平均减少- 42.9% (P≤0.01)。在40岁以上的女性中观察到囊肿体积减小的最佳动态- 66.8% vs. 52.5% (t = 0.97),而在40岁以下的男性中:27.1% vs. 30.5% (t = 0.29)。该研究证实了Aneza对单纯性肾囊肿患者的有效性,在作者看来,可以推荐一种膳食补充剂作为控制肾囊肿I-II生长的额外手段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Autologous vein graft in living donor kidney transplant (case report) Evaluation of the index of resistance and excretion of uromodulin in patients with predialysis CKD, taking into account the index of comorbidity COURSE PROGRAM “WKD in Ukraine: Advancing equitable access to pediatric nephrology care and optimal medication practice” KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis Selected abstracts from the World Kidney Day conference on March 11, 2024
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1